ICD-10-CM Billable Code

C44.81

Basal cell carcinoma of overlapping sites of skin

Clinical Classification Guidelines

Medical Intelligence & Overview

Basal cell carcinoma (BCC) is a common type of skin cancer that originates in the basal cells, the cells found in the lowest layer of the epidermis. When this type of cancer occurs across overlapping areas of the skin, it can involve multiple regions, making diagnosis and treatment more complex. The ICD-10 code C44.81 specifically refers to basal cell carcinoma affecting overlapping sites of skin, emphasizing the importance of comprehensive skin assessments for effective management.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. Fair skin that burns easily and has susceptibility to UV damage. A history of previous skin cancers or excessive sunburns. Exposure to radiation or certain carcinogenic chemicals. Weakened immune system due to medications, illnesses, or immune disorders. Genetic factors inherited from family members with skin cancer history.

Key Symptoms: New or changing skin growths or lesions that may appear shiny or translucent. Pearl-like or waxy bump, often with visible blood vessels. Ulcerated areas that bleed, ooze, or crust over, sometimes with a rolled border. Flat, pink, or flesh-colored patch with a raised, translucent border. Scar-like or pigmentless areas that are persistent and slowly growing. Lesions located on sun-exposed areas such as the face, ears, neck, or arms, but also potentially on other parts of the body.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of basal cell carcinoma of overlapping skin sites typically involves a thorough physical examination of suspicious lesions. A dermatologist may perform a biopsy—removing a small sample of tissue for microscopic analysis—to confirm the presence of cancer cells. Additional imaging tests or skin assessments may be used to determine the lesion's extent and involvement of adjacent areas, especially when multiple overlapping sites are affected.

Treatment Protocols: Treatment options depend on the size, location, and depth of the carcinoma, as well as the overall health of the patient. Common approaches include: - Surgical excision to remove the cancerous tissue. - Mohs micrographic surgery for precise removal, minimizing tissue loss, especially in cosmetically sensitive areas. - Curettage and electrodessication, suitable for small, superficial lesions. - Topical medications, such as fluorouracil or imiquimod, for surface-level or superficial cancers. - Photodynamic therapy, using light-activated drugs, primarily for superficial lesions. - Radiation therapy, in cases where surgery isn't feasible. Early and effective treatment is vital to prevent the spread and further skin damage associated with basal cell carcinoma.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.81 a billable ICD-10 code?
Yes, C44.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.81?
Clinical documentation must specify the nature of Basal cell carcinoma of overlapping sites of skin and any associated comorbidities for accurate reporting.

Cite this Clinical Reference